Cargando…
26-Week Repeated Dose Oral Toxicity Study of KCHO-1 in Sprague-Dawley Rats
OBJECTIVES: KCHO-1(Mecasin), also called Gamijakyakgamchobuja-tang originally, is a combination of some traditional herbal medicines in East Asia. This medicine has been used mainly for alleviating neuropathic pains for centuries in Korean traditional medicine. KCHO-1 was developed to treat pain, jo...
Autores principales: | Yang, Muhack, Lee, Seongjin, Wang, Tingting, Cha, Eunhye, Jang, Jongwon, Kim, Dongwoung, Song, Bong-Keun, Son, Ilhong, Kim, Joonyup, Kang, Hyung Won, Kim, Sungchul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Pharmacopuncture Institute (KPI)
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820473/ https://www.ncbi.nlm.nih.gov/pubmed/31673451 http://dx.doi.org/10.3831/KPI.2019.22.026 |
Ejemplares similares
-
A 4-week Repeated dose Oral Toxicity Study of Mecasin in Sprague-Dawley Rats to Determine the Appropriate Doses for a 13-week, Repeated Toxicity Test
por: Cha, Eunhye, et al.
Publicado: (2015) -
Analytical Method Validation of Gamijakyakgamchobuja-Tang (KCHO-1, Mecasin) Preparation
por: Wang, Tingting, et al.
Publicado: (2019) -
KCHO-1, a novel herbal anti-inflammatory compound, attenuates oxidative stress in an animal model of amyotrophic lateral sclerosis
por: Kook, Myung Geun, et al.
Publicado: (2017) -
A Pilot Study on Single-dose Toxicity Testing of Scolopendrid Pharmacopuncture in Sprague-Dawley Rats
por: Son, Ilhong, et al.
Publicado: (2014) -
KCHO-1, a Novel Antineuroinflammatory Agent, Inhibits Lipopolysaccharide-Induced Neuroinflammatory Responses through Nrf2-Mediated Heme Oxygenase-1 Expression in Mouse BV2 Microglia Cells
por: Lee, Dong-Sung, et al.
Publicado: (2014)